- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Taho Pharmaceuticals Ltd (6467)
Taho Pharmaceuticals Ltd stock price live, this page displays TW 6467 stock exchange data. View the 6467 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Taho Pharmaceuticals Ltd real time stock price chart below.
What Is the Taho Pharmaceuticals Ltd Stock Price Today?
The Taho Pharmaceuticals Ltd stock price today is 248.00.
What Is the Stock Symbol for Taho Pharmaceuticals Ltd?
The stock symbol for Taho Pharmaceuticals Ltd is "6467."
What Stock Exchange Does Taho Pharmaceuticals Ltd Trade On?
Taho Pharmaceuticals Ltd is listed and trades on the Taiwan stock exchange.
Is Taho Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Taho Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6467 quote. (ISIN: TW0006467004)
What Is the Taho Pharmaceuticals Ltd Stock Price Today?
The Taho Pharmaceuticals Ltd stock price today is 248.00.
What Is the Stock Symbol for Taho Pharmaceuticals Ltd?
The stock symbol for Taho Pharmaceuticals Ltd is "6467."
What Stock Exchange Does Taho Pharmaceuticals Ltd Trade On?
Taho Pharmaceuticals Ltd is listed and trades on the Taiwan stock exchange.
Is Taho Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Taho Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6467 quote. (ISIN: TW0006467004)
Taiwan
Currency in TWD
248.00
+13.00(+5.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
238.50
250.00
52 wk Range
100.50
302.00
6467 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
238.50250.00
52 wk Range
100.50302.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6467 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Sep 02, 2026
EPS / Forecast
-0.72 / --
Revenue / Forecast
1.3M / --
Compare 6467 to Peers and Sector
Metrics to compare | 6467 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6467PeersSector | |
|---|---|---|---|---|
P/E Ratio | −54.5x | −3.6x | −0.2x | |
PEG Ratio | 1.52 | 0.21 | 0.00 | |
Price/Book | 37.7x | 1.4x | 2.6x | |
Price / LTM Sales | 6,560.9x | 5.1x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 60.9% | |
Fair Value Upside | Unlock | −15.7% | 9.5% | Unlock |
Taho Pharmaceuticals Ltd., a commercial-stage pharmaceutical company, focuses on the development of drug delivery systems in transdermal and transmucosal systems in Taiwan. The company offers TAH4411 Ondansetron ODF, a selective serotonin 5HT3 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting. Its pipeline includes TAH3311 Apixaban oral film, which is in phase III; TAH3341, an anticoagulant apixaban ODF extended-release film, which is in preclinical stage. The company also develops TAH2211 Buprenorphine/Naloxone sublingual film for opioid addiction, which is in phase I; TAH2231 Naloxone Buccal film for opioid overdose, which is in phase I; TAH9922 Atomoxetine oral liquid, which is in phase I; and TAH9901 Methylphenidate patch for ADHD treatment, which is in phase I. Taho Pharmaceuticals Ltd. was founded in 2010 and is headquartered in Taipei, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Taho Pharmaceuticals (6467) Stock Price Today?
The Taho Pharmaceuticals stock price today is 248.00 TWD.
What Stock Exchange Does Taho Pharmaceuticals Trade On?
Taho Pharmaceuticals is listed and trades on the Taiwan Stock Exchange.
What Is the Stock Symbol for Taho Pharmaceuticals?
The stock symbol for Taho Pharmaceuticals is "6467."
What Is the Taho Pharmaceuticals Market Cap?
As of today, Taho Pharmaceuticals market cap is 13.00B TWD.
What Is Taho Pharmaceuticals's Earnings Per Share (TTM)?
The Taho Pharmaceuticals EPS (TTM) is -4.58.
When Is the Next Taho Pharmaceuticals Earnings Date?
Taho Pharmaceuticals will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is 6467 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Taho Pharmaceuticals Stock Split?
Taho Pharmaceuticals has split 0 times.
How Many Employees Does Taho Pharmaceuticals Have?
Taho Pharmaceuticals has 35 employees.
What is the current trading status of Taho Pharmaceuticals (6467)?
As of Nov 09, 2026, Taho Pharmaceuticals (6467) is trading at a price of 248.00 TWD, with a previous close of 248.00 TWD. The stock has fluctuated within a day range of 238.50 TWD to 250.00 TWD, while its 52-week range spans from 100.50 TWD to 302.00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.